COVID's endemic shift means a slowdown for virus-product makers
Demand for at-home tests will probably slow first while sales of more reliable PCRs will show more resilience, according to medical supply executives.
Source: japantimes.co.jp
Stay updated with breaking news from Roche Schwan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Demand for at-home tests will probably slow first while sales of more reliable PCRs will show more resilience, according to medical supply executives.